Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of C... ( KENILWORTH N.J. Aug. 11 /...)

HOME >> MEDICINE >> NEWS

Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R)

Date:8/11/2009

KENILWORTH, N.J., Aug. 11 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced an agreement with Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus Pharma, Inc. ("Orchid"), related to the generic manufacturing of certain formulations of CLARINEX(R) (desloratadine).

The agreement marks the end of all pending litigations filed and consolidated since 2006 in the U.S. District Court for the District of New Jersey against several generic drug manufacturing companies that had sought approval to market solid oral dosage forms of desloratadine products in the United States as generic brands prior to the expiration of certain Schering Corporation patents.

This agreement resolves all pending patent infringement litigation filed by Schering Corp. against Orchid and will allow Orchid to introduce a generic version of the CLARINEX(R) brand REDITABS (orally-disintegrating tablets) to be introduced into the U.S. market on January 1, 2012, and CLARINEX(R) brand 5 milligram tablets to be introduced on July 1, 2012. Schering holds various patents related to CLARINEX(R) that extend to 2022.

Beginning in September of 2006, Schering Corp. filed complaints for patent infringement against generic drug manufacturing companies that sought U.S. marketing rights for generic versions of CLARINEX tablets, CLARINEX REDITABS and/or CLARINEX-D12/-D 24 Extended Release Tablets. Since then, consent orders have been entered and/or settlements now have been reached in the cases against Anchen Pharmaceuticals, Inc., Belcher Pharmaceuticals, Inc., Caraco Pharmaceutical Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., GeoPharma, Inc., Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals, Ltd., Lupin Pharmaceuticals, Inc. and Lupin Ltd., Myla
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. Schering-Plough to Webcast Special Meeting of Shareholders
2. Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
3. New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
4. Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
5. Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
6. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
7. Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
8. Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
9. Schering-Plough Flips the Switch on 1.7 MW Rooftop Solar Panel System, One of the Largest in N.J., North America
10. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
11. Schering-Plough Reports Financial Results for 2009 First Quarter

Post Your Comments:

(Date:3/12/2010)... deal with Australia,s leading online department store,DealDirect.com.au.,The new, two-year ... of Netball,Australia, along with Holden and San Remo. ... ... Netball Australia has signed a major sponsorship deal with ... , The new, two-year sponsorship positions DealsDirect.com.au as one ...

(Date:3/11/2010)... Live in a Medically Underserved Area , ... , , ... ... ... NEW YORK , March 12 In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking ...

(Date:3/11/2010)... Area , ... , , ... ... ... 12 In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health care ...

(Date:3/11/2010)... Underserved Area , ... , , ... ... ... March 12 In releasing a new report on maternal health nationwide, Amnesty International today revealed that flaws and shocking disparities in maternal health ...

[0] Netball Australia Joins Forces with DealsDirect.com.au, Australia's Leading Online Department Store [0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; New Jersey is 35th Among All States in Maternal Mortality [0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; New Mexico is 49th Among All States in Maternal Mortality [0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; Mississippi is 45th Among All States in Maternal Mortality [0] New, National Amnesty International Report Finds Appalling U.S. Death Rate for Women Having Babies, Systemic Failures and Shocking Disparities in Maternal Health Care System; District of Columbia is 51st Among All States in Maternal Mortality

... or more hours per week of strenuous recreational activity ... 23 percent. According to a survey conducted on 15,000 ... protective effect against invasive breast cancer throughout a woman’s ... for most women physical activity may reduce the risk ...

... genetic regulator that triggers growth of stem cells during ... development of the lethal brain cancer malignant glioma. //In ... knocking out the function of a particular regulatory protein, ... said their findings suggest that targeting Olig2 could offer ...

... of keeping everything from happening at once' ,?????……….Anon ... controls the physiological processes of all living beings. ... of our cells there is a remarkable clock that is ... our body functions in accordance to a rhythm that traces ...

... University faculty members published in PLoS ONE, the international, ... Science (PLoS). Drs. Amin A. Muhammad Gadit and Gerry ... of depression among house holds in three capital cities ... ,Dr. Muhammad Gadit explained that Pakistan, among ...

... Drug Administration, FDA, warns consumers to restrain from ... the Internet.// ,The drugs advertised as ... a powerful anti-psychotic, which would eventually land victims ... that Ambien-a sleep aid, Xanax and Ativan- anti-anxiety ...

... has to be dealt with, at least for the health ... for Missouri-Columbia University have come out with disturbing study findings ... and pesticides. ,Prof Frederick vom Saal, lead researcher, ... of Science, attributed the obesity epidemic sweeping western countries to, ...

Other Medicine News:Health News:Active Lifestyle Reduces Risk of Invasive Breast Cancer 2 Health News:'Gateway' Gene Discovered for Brain Cancer 2 Health News:Rhythms of Life 2 Health News:Rhythms of Life 3 Health News:Be Careful What You Touch, It can Make You Fat 2

Active Lifestyle Reduces Risk of Invasive Breast Cancer 'Gateway' Gene Discovered for Brain Cancer Rhythms of Life Research Paper Examines Depression in 3 Cities in Pakistan The FDA Warns Consumers Against Purchase of Drugs on Web Be Careful What You Touch, It can Make You Fat

(Date:3/10/2010)... , March 10 OMNIlife science, Inc., is very ... Societe d,Etudes Recherches Fabrication (SERF)-Dedienne Sante of France for its NOVAE® Dual ... USA as soon as U.S. FDA approval of the product is achieved. ... ... ...

(Date:3/10/2010)... Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), ... the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. ... receive a standard review. , ... ... , ...

(Date:3/10/2010)... Robbins & Myers, Inc. (NYSE: ... results for its fiscal 2010 second quarter ending ... Wednesday, March 24, 2010 . A live webcast ... at 1:30 p.m., ET . Peter C. Wallace, ... Hix , Vice President and Chief Financial Officer, will ...

Breaking Medicine Technology:OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its 'ION free' Large Diameter Head Dual Mobility Acetabular Cup System 2 OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its 'ION free' Large Diameter Head Dual Mobility Acetabular Cup System 3 OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its 'ION free' Large Diameter Head Dual Mobility Acetabular Cup System 4 Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia 2 Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia 3 Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia 4 Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia 5 Robbins & Myers to Release Second Quarter Fiscal 2010 Financial Results 2 Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 1 Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting 51101 2 American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 1 American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 2 American Optometric Association Supports New Federal Health Report Findings 3A Vision Screening Methods for Seniors are Lacking 51097 3 Shaw to receive prestigious honor for plant pathology research 9171 1

[0] OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its 'ION free' Large Diameter Head Dual Mobility Acetabular Cup System [0] Dainippon Sumitomo Pharma America Announces FDA Acceptance of Lurasidone New Drug Application for Treatment of Schizophrenia [0] Robbins & Myers to Release Second Quarter Fiscal 2010 Financial Results

... Females Regenerate Skeletal Muscle More,Efficiently than Male Cells, PITTSBURGH, ... muscle have a greater ability to regenerate skeletal,muscle tissue ... of Pittsburgh of UPMC. , The study, which is ... of Cell Biology, is the first ever to report ...

... Health Organizations Unite to Help Educate on Good,Diabetes ... Other Serious,Health Problems, SEATTLE, April 10, 2007 /PRNewswire/ ... cost of type 2 diabetes,complications shows that an ... type 2 diabetes have at least one of ...

Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2 The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6 First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7

The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America

... a series of bronchofiberscopes with electrosurgical capability, ... meet the demand for expanded bronchoscopic diagnostic ... new control section and ergonomic design to ... a wider field of view, a smaller ...

Indications For Usage: , Thoracic surgery. , Broncho-spirometry. , Thoracoscopies. , Differential or selective lung ventilation. ...

Indications For Usage: , Thoracic surgery. , Broncho-spirometry. , Thoracoscopies. , Differential or selective lung ventilation. , Lung Lavage. ...

... Double lumen tubes ... ventilation., ,Each ... is packaged with ... adaptors, suction catheters ...

Medicine Products:

BF-P40 Fiber Bronchoscope Broncho-Cath® Endobronchial Tube with CPAP System Broncho-Cath® Endobronchial Tube Sheridan SHER-I-BRONCH® Endobrochial Tube - Right-Sided

Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of C...( KENILWORTH N.J. Aug. 11 /...),Health